Showing 39,621 - 39,640 results of 103,005 for search '(( e point decrease ) OR ( 5 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.09s Refine Results
  1. 39621
  2. 39622

    Epitope mapping reveals a change in the CD8 T cell repertoire and in immunodominance. by Sama Adnan (693011)

    Published 2015
    “…<p>(A) Of the 37 CD8 T cell epitopes mapped for 6 SIVΔnef-vaccinated animals at week 5, only 14 epitopes were recognized at week 20. …”
  3. 39623

    Crystal Structures of Lanthanide(III) Complexes with Cyclen Derivative Bearing Three Acetate and One Methylphosphonate Pendants by Pavel Vojtíšek (2674720)

    Published 2005
    “…A series of lanthanide(III) complexes formulated as M[Ln(Hdo3ap)]·<i>x</i>H<sub>2</sub>O (M = Li or H and Ln = Tb, Dy, Er, Lu, and Y) with the monophosphonate analogue of H<sub>4</sub>dota, 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic-10-methylphosphonic acid (H<sub>5</sub>do3ap), was prepared in the solid state and studied using X-ray crystallography. …”
  4. 39624

    Peptides protect corneas from infection of <i>A. fumigatus</i> in vivo. by Ge Zhao (178636)

    Published 2012
    “…<p>(A–B) Treatment of corneas with peptide Pc-C or Pc-E around infection significantly decreased the disease scores at day 3 and 5 of post infection when compared with mock treated eyes (<i>P</i><0.05), but to less extent than Natamycin. …”
  5. 39625
  6. 39626
  7. 39627
  8. 39628
  9. 39629

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  10. 39630

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  11. 39631

    DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  12. 39632

    DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

    Published 2022
    “…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).</p>Results<p>The humoral immune response in the “vaccination” cohort was higher at 3 months, but lower at 10 months, compared to the “infection” cohort due to a faster decline. …”
  13. 39633
  14. 39634
  15. 39635

    Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer by Kelly Coffey (129302)

    Published 2012
    “…<div><p>Tip60 (KAT5) is a histone acetyltransferase (HAT enzyme) involved in multiple cellular processes including transcriptional regulation, DNA damage repair and cell signalling. …”
  16. 39636
  17. 39637
  18. 39638

    <sup>99m</sup>Tc-Labeled RGD-BBN Peptide for Small-Animal SPECT/CT of Lung Carcinoma by Zhaofei Liu (1583062)

    Published 2012
    “…We recently designed and synthesized a Glu-c­(RGDyK)-bombesin (RGD-BBN) heterodimeric peptide exhibiting a dual integrin α<sub>v</sub>β<sub>3</sub> and gastrin-releasing peptide receptor (GRPR) targeting property. …”
  19. 39639
  20. 39640

    Follow-up outcomes of asymptomatic brucellosis: a systematic review and meta-analysis by Fande Li (11457104)

    Published 2023
    “…Regarding the follow-up outcomes, we examined the presence or absence of symptoms and decreased serum agglutination test (SAT) titre. During the 0.5–18 months follow-up period, the pooled prevalence of appearing symptomatic was 15.4% (95% CI 2.1%–34.3%), cases that remained asymptomatic were 40.3% (95% CI 16.6%–65.8%), and decreased SAT titre was observed in 36.5% (95% CI 11.6%–66.1%). …”